- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PharmaBlock Sciences Nanjing Inc (300725)
The NJ PharmaBlock share price today is 43.98, view SZ 300725 stock exchange data. Track the latest NJ PharmaBlock share price with real-time updates on 300725 stock performance including market cap, day range, 52-week range and dividend yield. Access 300725 charts, earnings dates and analyst estimates to support your investment decisions.
Shenzhen
Currency in CNY
43.98
-0.05(-0.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.83
45.34
52 wk Range
30.90
57.55
Earnings results expected in 11 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.8345.34
52 wk Range
30.9057.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300725 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
11-08-2026
EPS / Forecast
0.22 / --
Revenue / Forecast
551M / --
Compare 300725 to Peers and Sector
Metrics to compare | 300725 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300725PeersSector | |
|---|---|---|---|---|
P/E Ratio | 48.6x | 37.6x | −0.3x | |
PEG Ratio | −26.70 | 0.93 | 0.00 | |
Price/Book | 2.2x | 2.7x | 2.6x | |
Price / LTM Sales | 4.8x | 5.2x | 2.9x | |
Upside (Analyst Target) | - | 31.0% | 66.7% | |
Fair Value Upside | Unlock | 15.0% | 9.6% | Unlock |
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small molecule drug substance CDMO services, including optimal route scouting; FFS and FTE for process research and development of RSMs, intermediates, and APIs; impurity studies and synthesis; solid state chemistry; analytical development and quality control; cGMP manufacturing of intermediates and APIs; and CMC regulatory filing support. In addition, it offers small molecule DP CDMO services, such as candidate screening and selection, early development, full development, registration, and post-approval; and new modality services, including target protein degrader, peptide, oligonucleotide, and ADC services. PharmaBlock Sciences (Nanjing), Inc. was founded in 2006 and is based in Nanjing, the People's Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the NJ PharmaBlock (300725) Share Price Today?
The NJ PharmaBlock share price today is 43.98.
What is the current NJ PharmaBlock (300725) share price and day range?
As of 19-10-2026, the NJ PharmaBlock share price is 43.98, with a previous close of 43.98. The share price has ranged from 41.83 to 45.34 today, while the 52-week range spans from 30.90 to 57.55.
What Is the NJ PharmaBlock Market Cap?
As of today, NJ PharmaBlock market cap is 10.25B.
Does NJ PharmaBlock Pay Dividends? What's The Current Dividend Yield?
The NJ PharmaBlock dividend yield is 0.9%%.
What Is NJ PharmaBlock's Earnings Per Share (TTM)?
The NJ PharmaBlock EPS (TTM) is 0.94.
When Is the Next NJ PharmaBlock Earnings Date?
NJ PharmaBlock will release its next earnings report on 30-10-2026.
From a Technical Analysis Perspective, Is 300725 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does NJ PharmaBlock Trade On?
NJ PharmaBlock is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for NJ PharmaBlock?
The stock symbol for NJ PharmaBlock is "300725."
How Many Times Has NJ PharmaBlock Stock Split?
NJ PharmaBlock has split 3 times.
How Many Employees Does NJ PharmaBlock Have?
NJ PharmaBlock has 2593 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.